IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection

por Bogdanovic, J., Babic, I., Adzic Vukicevic, T., Lalic, K., Popovic, D., Lalic, N.
Publicado 2022

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection

por Babic, I., Bogdanovic, J., Adzic Vukicevic, T., Lalic, K., Popovic, D., Lalic, N.
Publicado 2022

The Diabetic Foot

por Migdalis, I., Czupryniak, L., Lalic, N., Leslie, R. D., Papanas, N., Valensi, P.
Publicado 2017

Diabetic Microvascular Complications

por Migdalis, I., Czupryniak, L., Lalic, N., Leslie, R. D., Papanas, N., Valensi, P.
Publicado 2018

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

por Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., Simó, R.
Publicado 2009

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study

por Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters‐Weijnen, C., Forsén, T., Galstyan, G., Geelhoed‐Duijvestijn, P., Goldfracht, M., Gydesen, H., Kapur, R., Lalic, N., Ludvik, B., Moberg, E., Pedersen‐Bjergaard, U., Ramachandran, A.
Publicado 2016

Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study

por Lloyd, C. E., Sartorius, N., Ahmed, H. U., Alvarez, A., Bahendeka, S., Bobrov, A. E., Burti, L., Chaturvedi, S. K., Gaebel, W., de Girolamo, G., Gondek, T. M., Guinzbourg, M., Heinze, M. G., Khan, A., Kiejna, A., Kokoszka, A., Kamala, T., Lalic, N. M., Lecic-Tosevski, D., Mannucci, E., Mankovsky, B., Müssig, K., Mutiso, V., Ndetei, D., Nouwen, A., Rabbani, G., Srikanta, S. S., Starostina, E. G., Shevchuk, M., Taj, R., Valentini, U., van Dam, K., Vukovic, O., Wölwer, W.
Publicado 2020